Arcutis Biotherapeutics, Inc. (ARQT)
24.03
-0.50
(-2.04%)
USD |
NASDAQ |
Apr 20, 09:53
Arcutis Biotherapeutics SG&A Expense (Quarterly) : 78.98M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Repligen Corp. | 74.36M |
| ACADIA Pharmaceuticals, Inc. | 155.62M |
| Corcept Therapeutics, Inc. | 130.24M |
| Amicus Therapeutics, Inc. | 117.08M |
| ADMA Biologics, Inc. | 24.64M |